Acadia Pharmaceuticals Inc (ACAD)

CIK 1070494 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acadia Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 11, 20268-K0001193125-26-389400
Aug 7, 2026SCHEDULE 13G0000093751-26-000400
Aug 7, 202640001899977-26-000008
Aug 5, 20261440001967940-26-000042
Aug 5, 202610-Q0001193125-26-333243
Aug 4, 20268-K0001193125-26-332858
Jul 31, 202640001861477-26-000005
Jun 29, 202640001816160-26-000009
Jun 26, 20261440001967940-26-000036
Jun 10, 2026S-80001193125-26-265809
Jun 2, 202640001193125-26-253632
Jun 1, 202640001560782-26-000002
Jun 1, 202640001826361-26-000002
Jun 1, 202640001365619-26-000002
Jun 1, 202640001865210-26-000002
Jun 1, 202640001177917-26-000009
Jun 1, 202640001604689-26-000009
May 29, 20268-K0001193125-26-248242
May 27, 202640001816160-26-000008
May 26, 20261440001950047-26-005016
May 7, 202610-Q0001193125-26-209731
May 6, 20268-K0001193125-26-209253
May 5, 202640001816160-26-000007
May 5, 202640001899977-26-000007
May 1, 20268-K0001193125-26-197957